New eye drug shows promise for Diabetes-Related vision loss

NCT ID NCT05301751

Completed Disease control Sponsor: Allgenesis Biotherapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2a trial tested a new biologic drug called AG-73305, given as an injection into the eye, in 25 adults with diabetic macular edema (DME), a common cause of vision loss in people with diabetes. The study aimed to check the drug's safety and how well it works over 6 months, measuring changes in vision and retinal swelling. Because it's an early-stage study with a small number of participants, the results are preliminary but will help guide future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AG-73305 (a biologic drug given as an eye injection)
What this could lead to: If successful, this could lead to a new treatment option for diabetic macular edema that may improve vision and reduce retinal swelling.
What could go wrong: This is a small, early-phase trial with only 25 participants, so results may not apply to everyone. The drug is injected directly into the eye, which carries risks like infection or inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic macular edema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC MACULAR EDEMA

Contacts and locations

Locations

Center of Macula and Retina Disease

Winter Haven, Florida, 33880, United States
Retina Research Institute of Texas

Abilene, Texas, 79606, United States
Retina Vitreous Associates of Florida

St. Petersburg, Florida, 33711, United States
Strategic Clinical Research Group, LLC

Willow Park, Texas, 76087, United States
Texas Retina Associates

Fort Worth, Texas, 76104, United States
Valley Retina Institute

McAllen, Texas, 78503, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.